Investegate |Syncona Limited Announcements | Syncona Limited: Achilles reports Q4 and full year 2022 Results
Investegate announcements from Syncona Limited, Achilles reports Q4 and full year 2022 Results
Source: investegate.co.uk
📰 Achilles Clonality Engine News
Achilles Clonality Engine News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Achilles Clonality Engine. Real-time updates on events, politics, business and more.
Achilles Therapeutics Announces Grant of US Patent on Immunotherapies Targeting Clonal Neoantigens Identified Using Proprietary Method
Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, today announced that United States (US) patent 11,504,398 has been granted. The patent covers the treatment of patients with an immunotherapy targeting clonal ...
United States United Kingdom Sergio Quezada Charles Swanton Cancer Research United Kingdom Achilles Clonality Engine
Source: pharmiweb.com
Achilles Therapeutics PLC: Achilles Therapeutics Announces Grant of US Patent on Immunotherapies Targeting Clonal Neoantigens Identified Using Proprietary Method
- US patent is for an immunotherapy targeting clonal neoantigens identified by the Achilles Clonality Engine (ACE), including vaccine, antibody, and autologous T cell therapy approaches -LONDON, Nov. 22
Source: finanznachrichten.de